FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Stem Cell Rev Rep / Characterization and use of Equine Bone Marrow Mesenchymal S...
Stem cell reviews and reports2017; 13(5); 611-630; doi: 10.1007/s12015-017-9748-y

Characterization and use of Equine Bone Marrow Mesenchymal Stem Cells in Equine Cartilage Engineering. Study of their Hyaline Cartilage Forming Potential when Cultured under Hypoxia within a Biomaterial in the Presence of BMP-2 and TGF-ß1.

Abstract: Articular cartilage presents a poor capacity for self-repair. Its structure-function are frequently disrupted or damaged upon physical trauma or osteoarthritis in humans. Similar musculoskeletal disorders also affect horses and are the leading cause of poor performance or early retirement of sport- and racehorses. To develop a therapeutic solution for horses, we tested the autologous chondrocyte implantation technique developed on human bone marrow (BM) mesenchymal stem cells (MSCs) on horse BM-MSCs. This technique involves BM-MSC chondrogenesis using a combinatory approach based on the association of 3D-culture in collagen sponges, under hypoxia in the presence of chondrogenic factors (BMP-2 + TGF-β) and siRNA to knockdown collagen I and HtrA1. Horse BM-MSCs were characterized before being cultured in chondrogenic conditions to find the best combination to enhance, stabilize, the chondrocyte phenotype. Our results show a very high proliferation of MSCs and these cells satisfy the criteria defining stem cells (pluripotency-surface markers expression). The combination of BMP-2 + TGF-β strongly induces the chondrogenic differentiation of MSCs and prevents HtrA1 expression. siRNAs targeting Col1a1 and Htra1 were functionally validated. Ultimately, the combined use of specific culture conditions defined here with specific growth factors and a Col1a1 siRNAs (50 nM) association leads to the in vitro synthesis of a hyaline-type neocartilage whose chondrocytes present an optimal phenotypic index similar to that of healthy, differentiated chondrocytes. Our results lead the way to setting up pre-clinical trials in horses to better understand the reaction of neocartilage substitute and to carry out a proof-of-concept of this therapeutic strategy on a large animal model.
Get Full Text
Publication Date: 2017-06-10 PubMed ID: 28597211DOI: 10.1007/s12015-017-9748-yGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article explores how equine bone marrow mesenchymal stem cells (BM-MSCs) can be used and developed into hyaline cartilage through a specific technique, potentially providing a solution for treating musculoskeletal disorders in horses.

Understanding the Study

The researchers have been looking at ways to repair articular cartilage, which does not naturally repair itself well. Damage to this type of cartilage can dramatically impact the performance of sport and racehorses, often leading to early retirement.

  • The autologous chondrocyte implantation technique, which has previously been successful with human bone marrow stem cells, was used on horse BM-MSCs in this study.
  • This technique required growing the stem cells in 3D collagen sponges, under low-oxygen conditions. Growth factors known to promote the formation of chondrocytes, BMP-2 and TGF-β, were applied to the cells. Additionally, the researchers used siRNA to silence the genes that produce collagen I and HtrA1, trying to stabilize the chondrocyte phenotype.

Key Findings

The BM-MSCs from horse marrow met the criteria for being stem cells, including the ability to proliferate extensively. Researchers found the cells to be very adaptable, showing different characteristics based on the conditions in which they were grown.

  • The combination of BMP-2 and TGF-β significantly induced chondrogenic differentiation i.e., they helped stem cells become more similar to chondrocyte (cartilage cells) and prevented the expression of HtrA1, a gene involved in the degradation of extracellular matrix.
  • The use of siRNA was successfully able to target and inhibit the collagen I (Col1a1) and HtrA1 gene expression.
  • The in vitro (lab) conditions led to the creation of hyaline-type neocartilage. The derived chondrocytes displayed a phenotype similar to healthy, differentiated chondrocytes. This new cartilage potentially holds the key to repairing cartilage damage in horses.

Implications and Future Research

These positive results suggest that pre-clinical trials on horses could be a feasible next step. This future research would help to better understand how the newly-created cartilage integrates into existing tissue, and validate the therapeutic strategy in a large, living model.

Cite This Article

APA
Branly T, Bertoni L, Contentin R, Rakic R, Gomez-Leduc T, Desancé M, Hervieu M, Legendre F, Jacquet S, Audigié F, Denoix JM, Demoor M, Galéra P. (2017). Characterization and use of Equine Bone Marrow Mesenchymal Stem Cells in Equine Cartilage Engineering. Study of their Hyaline Cartilage Forming Potential when Cultured under Hypoxia within a Biomaterial in the Presence of BMP-2 and TGF-ß1. Stem Cell Rev Rep, 13(5), 611-630. https://doi.org/10.1007/s12015-017-9748-y

Publication

Stem cell reviews and reports
ISSN: 2629-3277
NlmUniqueID: 101752767
Country: United States
Language: English
Volume: 13
Issue: 5
Pages: 611-630

Researcher Affiliations

Branly, Thomas
  • Normandy University, Caen, France.
  • UNICAEN BIOTARGEN (Biologie, génétique et thérapies ostéoarticulaires et respiratoires), EA7450; UFR Santé, Université de Caen Normandie, 14000, Caen, France.
Bertoni, Lélia
  • Center of Imaging and Research on Locomotor Affections in Equines, Ecole Vétérinaire d'Alfort, Université Paris-Est, 14430, Goustranville, France.
Contentin, Romain
  • Normandy University, Caen, France.
  • UNICAEN BIOTARGEN (Biologie, génétique et thérapies ostéoarticulaires et respiratoires), EA7450; UFR Santé, Université de Caen Normandie, 14000, Caen, France.
Rakic, Rodolphe
  • Normandy University, Caen, France.
  • UNICAEN BIOTARGEN (Biologie, génétique et thérapies ostéoarticulaires et respiratoires), EA7450; UFR Santé, Université de Caen Normandie, 14000, Caen, France.
Gomez-Leduc, Tangni
  • Normandy University, Caen, France.
  • UNICAEN BIOTARGEN (Biologie, génétique et thérapies ostéoarticulaires et respiratoires), EA7450; UFR Santé, Université de Caen Normandie, 14000, Caen, France.
Desancé, Mélanie
  • Normandy University, Caen, France.
  • UNICAEN BIOTARGEN (Biologie, génétique et thérapies ostéoarticulaires et respiratoires), EA7450; UFR Santé, Université de Caen Normandie, 14000, Caen, France.
Hervieu, Magalie
  • Normandy University, Caen, France.
  • UNICAEN BIOTARGEN (Biologie, génétique et thérapies ostéoarticulaires et respiratoires), EA7450; UFR Santé, Université de Caen Normandie, 14000, Caen, France.
Legendre, Florence
  • Normandy University, Caen, France.
  • UNICAEN BIOTARGEN (Biologie, génétique et thérapies ostéoarticulaires et respiratoires), EA7450; UFR Santé, Université de Caen Normandie, 14000, Caen, France.
Jacquet, Sandrine
  • Center of Imaging and Research on Locomotor Affections in Equines, Ecole Vétérinaire d'Alfort, Université Paris-Est, 14430, Goustranville, France.
Audigié, Fabrice
  • Center of Imaging and Research on Locomotor Affections in Equines, Ecole Vétérinaire d'Alfort, Université Paris-Est, 14430, Goustranville, France.
Denoix, Jean-Marie
  • Center of Imaging and Research on Locomotor Affections in Equines, Ecole Vétérinaire d'Alfort, Université Paris-Est, 14430, Goustranville, France.
Demoor, Magali
  • Normandy University, Caen, France.
  • UNICAEN BIOTARGEN (Biologie, génétique et thérapies ostéoarticulaires et respiratoires), EA7450; UFR Santé, Université de Caen Normandie, 14000, Caen, France.
Galéra, Philippe
  • Normandy University, Caen, France. philippe.galera@unicaen.fr.
  • UNICAEN BIOTARGEN (Biologie, génétique et thérapies ostéoarticulaires et respiratoires), EA7450; UFR Santé, Université de Caen Normandie, 14000, Caen, France. philippe.galera@unicaen.fr.

MeSH Terms

  • Animals
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / drug effects
  • Bone Marrow Cells / metabolism
  • Bone Morphogenetic Protein 2 / pharmacology
  • Cell Differentiation / drug effects
  • Cell Hypoxia
  • Cell Proliferation / drug effects
  • Chondrocytes / cytology
  • Chondrocytes / drug effects
  • Chondrocytes / metabolism
  • Chondrogenesis / drug effects
  • Chondrogenesis / genetics
  • Collagen Type I / antagonists & inhibitors
  • Collagen Type I / genetics
  • Collagen Type I / metabolism
  • Collagen Type I, alpha 1 Chain
  • Gene Expression Regulation
  • High-Temperature Requirement A Serine Peptidase 1 / antagonists & inhibitors
  • High-Temperature Requirement A Serine Peptidase 1 / genetics
  • High-Temperature Requirement A Serine Peptidase 1 / metabolism
  • Horses
  • Hyaline Cartilage / cytology
  • Hyaline Cartilage / metabolism
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / drug effects
  • Mesenchymal Stem Cells / metabolism
  • Primary Cell Culture
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Signal Transduction
  • Tissue Engineering / methods
  • Transforming Growth Factor beta1 / pharmacology

References

This article includes 53 references
  1. Aigner T, Cook JL, Gerwin N, Glasson SS, Laverty S, Little CB, McIlwraith W, Kraus VB. Histopathology atlas of animal model systems - overview of guiding principles.. Osteoarthritis Cartilage 2010 Oct;18 Suppl 3:S2-6.
    pubmed: 20864020doi: 10.1016/j.joca.2010.07.013google scholar: lookup
  2. Chen G, Deng C, Li YP. TGF-β and BMP signaling in osteoblast differentiation and bone formation.. Int J Biol Sci 2012;8(2):272-88.
    pubmed: 22298955doi: 10.7150/ijbs.2929google scholar: lookup
  3. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, McKenzie S, Broxmeyer HE, Moore MA. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny.. Blood 1980 Aug;56(2):289-301.
    pubmed: 6994839
  4. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.. Stem Cells 2006 May;24(5):1294-301.
    pubmed: 16410387doi: 10.1634/stemcells.2005-0342google scholar: lookup
  5. Aigner T, Stöve J. Collagens--major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair.. Adv Drug Deliv Rev 2003 Nov 28;55(12):1569-93.
    pubmed: 14623402doi: 10.1016/j.addr.2003.08.009google scholar: lookup
  6. Legendre F, Ollitrault D, Gomez-Leduc T, Bouyoucef M, Hervieu M, Gruchy N, Mallein-Gerin F, Leclercq S, Demoor M, Galéra P. Enhanced chondrogenesis of bone marrow-derived stem cells by using a combinatory cell therapy strategy with BMP-2/TGF-β1, hypoxia, and COL1A1/HtrA1 siRNAs.. Sci Rep 2017 Jun 13;7(1):3406.
    pubmed: 28611369doi: 10.1038/s41598-017-03579-ygoogle scholar: lookup
  7. Pascucci L, Curina G, Mercati F, Marini C, Dall'Aglio C, Paternesi B, Ceccarelli P. Flow cytometric characterization of culture expanded multipotent mesenchymal stromal cells (MSCs) from horse adipose tissue: towards the definition of minimal stemness criteria.. Vet Immunol Immunopathol 2011 Dec 15;144(3-4):499-506.
    pubmed: 21839521doi: 10.1016/j.vetimm.2011.07.017google scholar: lookup
  8. Chalk AM, Wahlestedt C, Sonnhammer EL. Improved and automated prediction of effective siRNA.. Biochem Biophys Res Commun 2004 Jun 18;319(1):264-74.
    pubmed: 15158471doi: 10.1016/j.bbrc.2004.04.181google scholar: lookup
  9. Mayer N, Lopa S, Talò G, Lovati AB, Pasdeloup M, Riboldi SA, Moretti M, Mallein-Gerin F. Interstitial Perfusion Culture with Specific Soluble Factors Inhibits Type I Collagen Production from Human Osteoarthritic Chondrocytes in Clinical-Grade Collagen Sponges.. PLoS One 2016;11(9):e0161479.
    pubmed: 27584727doi: 10.1371/journal.pone.0161479google scholar: lookup
  10. Callender GR, Kelser RA. Degenerative arthritis: A comparison of the pathological changes in man and equines.. Am J Pathol 1938 May;14(3):253-272.9.
    pubmed: 19970389
  11. Snøve O Jr, Holen T. Many commonly used siRNAs risk off-target activity.. Biochem Biophys Res Commun 2004 Jun 18;319(1):256-63.
    pubmed: 15158470doi: 10.1016/j.bbrc.2004.04.175google scholar: lookup
  12. Lai CH, Chen SC, Chiu LH, Yang CB, Tsai YH, Zuo CS, Chang WH, Lai WF. Effects of low-intensity pulsed ultrasound, dexamethasone/TGF-beta1 and/or BMP-2 on the transcriptional expression of genes in human mesenchymal stem cells: chondrogenic vs. osteogenic differentiation.. Ultrasound Med Biol 2010 Jun;36(6):1022-33.
    pubmed: 20510190doi: 10.1016/j.ultrasmedbio.2010.03.014google scholar: lookup
  13. Malda J, Benders KE, Klein TJ, de Grauw JC, Kik MJ, Hutmacher DW, Saris DB, van Weeren PR, Dhert WJ. Comparative study of depth-dependent characteristics of equine and human osteochondral tissue from the medial and lateral femoral condyles.. Osteoarthritis Cartilage 2012 Oct;20(10):1147-51.
    pubmed: 22781206doi: 10.1016/j.joca.2012.06.005google scholar: lookup
  14. Brittberg M. Autologous chondrocyte transplantation.. Clin Orthop Relat Res 1999 Oct;(367 Suppl):S147-55.
    pubmed: 10546643doi: 10.1097/00003086-199910001-00016google scholar: lookup
  15. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, Benes V, Blake J, Pfister S, Eckstein V, Ho AD. Replicative senescence of mesenchymal stem cells: a continuous and organized process.. PLoS One 2008 May 21;3(5):e2213.
    pubmed: 18493317doi: 10.1371/journal.pone.0002213google scholar: lookup
  16. Vidal MA, Walker NJ, Napoli E, Borjesson DL. Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cord tissue.. Stem Cells Dev 2012 Jan 20;21(2):273-83.
    pubmed: 21410356doi: 10.1089/scd.2010.0589google scholar: lookup
  17. Chamberland A, Wang E, Jones AR, Collins-Racie LA, LaVallie ER, Huang Y, Liu L, Morris EA, Flannery CR, Yang Z. Identification of a novel HtrA1-susceptible cleavage site in human aggrecan: evidence for the involvement of HtrA1 in aggrecan proteolysis in vivo.. J Biol Chem 2009 Oct 2;284(40):27352-9.
    pubmed: 19657146doi: 10.1074/jbc.M109.037051google scholar: lookup
  18. Katz JN, Losina E, Lohmander LS. OARSI Clinical Trials Recommendations: Design and conduct of clinical trials of surgical interventions for osteoarthritis.. Osteoarthritis Cartilage 2015 May;23(5):798-802.
    pubmed: 25952350doi: 10.1016/j.joca.2015.02.024google scholar: lookup
  19. Hillmann A, Ahrberg AB, Brehm W, Heller S, Josten C, Paebst F, Burk J. Comparative Characterization of Human and Equine Mesenchymal Stromal Cells: A Basis for Translational Studies in the Equine Model.. Cell Transplant 2016;25(1):109-24.
    pubmed: 25853993doi: 10.3727/096368915X687822google scholar: lookup
  20. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation.. N Engl J Med 1994 Oct 6;331(14):889-95.
    pubmed: 8078550doi: 10.1056/NEJM199410063311401google scholar: lookup
  21. Demoor M, Ollitrault D, Gomez-Leduc T, Bouyoucef M, Hervieu M, Fabre H, Lafont J, Denoix JM, Audigié F, Mallein-Gerin F, Legendre F, Galera P. Cartilage tissue engineering: molecular control of chondrocyte differentiation for proper cartilage matrix reconstruction.. Biochim Biophys Acta 2014 Aug;1840(8):2414-40.
    pubmed: 24608030doi: 10.1016/j.bbagen.2014.02.030google scholar: lookup
  22. Arnhold SJ, Goletz I, Klein H, Stumpf G, Beluche LA, Rohde C, Addicks K, Litzke LF. Isolation and characterization of bone marrow-derived equine mesenchymal stem cells.. Am J Vet Res 2007 Oct;68(10):1095-105.
    pubmed: 17916017doi: 10.2460/ajvr.68.10.1095google scholar: lookup
  23. Danišovič Ľ, Boháč M, Zamborský R, Oravcová L, Provazníková Z, Csöbönyeiová M, Varga I. Comparative analysis of mesenchymal stromal cells from different tissue sources in respect to articular cartilage tissue engineering.. Gen Physiol Biophys 2016 Apr;35(2):207-14.
    pubmed: 26891275doi: 10.4149/gpb_2015044google scholar: lookup
  24. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.. Cell 1993 Dec 3;75(5):843-54.
    pubmed: 8252621doi: 10.1016/0092-8674(93)90529-ygoogle scholar: lookup
  25. Oka C, Tsujimoto R, Kajikawa M, Koshiba-Takeuchi K, Ina J, Yano M, Tsuchiya A, Ueta Y, Soma A, Kanda H, Matsumoto M, Kawaichi M. HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins.. Development 2004 Mar;131(5):1041-53.
    pubmed: 14973287doi: 10.1242/dev.00999google scholar: lookup
  26. Ollitrault D, Legendre F, Drougard C, Briand M, Benateau H, Goux D, Chajra H, Poulain L, Hartmann D, Vivien D, Shridhar V, Baldi A, Mallein-Gerin F, Boumediene K, Demoor M, Galera P. BMP-2, hypoxia, and COL1A1/HtrA1 siRNAs favor neo-cartilage hyaline matrix formation in chondrocytes.. Tissue Eng Part C Methods 2015 Feb;21(2):133-47.
    pubmed: 24957638doi: 10.1089/ten.TEC.2013.0724google scholar: lookup
  27. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.. Cytotherapy 2006;8(4):315-7.
    pubmed: 16923606doi: 10.1080/14653240600855905google scholar: lookup
  28. Tian Y, Guo R, Shi B, Chen L, Yang L, Fu Q. MicroRNA-30a promotes chondrogenic differentiation of mesenchymal stem cells through inhibiting Delta-like 4 expression.. Life Sci 2016 Mar 1;148:220-8.
    pubmed: 26872979doi: 10.1016/j.lfs.2016.02.031google scholar: lookup
  29. Ronzière MC, Perrier E, Mallein-Gerin F, Freyria AM. Chondrogenic potential of bone marrow- and adipose tissue-derived adult human mesenchymal stem cells.. Biomed Mater Eng 2010;20(3):145-58.
    pubmed: 20930322doi: 10.3233/BME-2010-0626google scholar: lookup
  30. Duval E, Leclercq S, Elissalde JM, Demoor M, Galéra P, Boumédiene K. Hypoxia-inducible factor 1alpha inhibits the fibroblast-like markers type I and type III collagen during hypoxia-induced chondrocyte redifferentiation: hypoxia not only induces type II collagen and aggrecan, but it also inhibits type I and type III collagen in the hypoxia-inducible factor 1alpha-dependent redifferentiation of chondrocytes.. Arthritis Rheum 2009 Oct;60(10):3038-48.
    pubmed: 19790048doi: 10.1002/art.24851google scholar: lookup
  31. Bianchessi M, Chen Y, Durgam S, Pondenis H, Stewart M. Effect of Fibroblast Growth Factor 2 on Equine Synovial Fluid Chondroprogenitor Expansion and Chondrogenesis.. Stem Cells Int 2016;2016:9364974.
    pubmed: 26839571doi: 10.1155/2016/9364974google scholar: lookup
  32. Gómez-Leduc T, Hervieu M, Legendre F, Bouyoucef M, Gruchy N, Poulain L, de Vienne C, Herlicoviez M, Demoor M, Galéra P. Chondrogenic commitment of human umbilical cord blood-derived mesenchymal stem cells in collagen matrices for cartilage engineering.. Sci Rep 2016 Sep 8;6:32786.
    pubmed: 27604951doi: 10.1038/srep32786google scholar: lookup
  33. Maneix L, Servent A, Porée B, Ollitrault D, Branly T, Bigot N, Boujrad N, Flouriot G, Demoor M, Boumediene K, Moslemi S, Galéra P. Up-regulation of type II collagen gene by 17β-estradiol in articular chondrocytes involves Sp1/3, Sox-9, and estrogen receptor α.. J Mol Med (Berl) 2014 Nov;92(11):1179-200.
    pubmed: 25081415doi: 10.1007/s00109-014-1195-5google scholar: lookup
  34. Liu Y, He L, Tian J. [Effect of basic fibroblast growth factor and parathyroid hormone-related protein on early and late chondrogenic differentiation of rabbit bone marrow mesenchymal stem cells induced by transforming growth factor beta 1].. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2013 Feb;27(2):199-206.
    pubmed: 23596689
  35. Campbell TM, Churchman SM, Gomez A, McGonagle D, Conaghan PG, Ponchel F, Jones E. Mesenchymal Stem Cell Alterations in Bone Marrow Lesions in Patients With Hip Osteoarthritis.. Arthritis Rheumatol 2016 Jul;68(7):1648-59.
    pubmed: 26866940doi: 10.1002/art.39622google scholar: lookup
  36. Sensebé L, Bourin P, Tarte K. Good manufacturing practices production of mesenchymal stem/stromal cells.. Hum Gene Ther 2011 Jan;22(1):19-26.
    pubmed: 21028982doi: 10.1089/hum.2010.197google scholar: lookup
  37. Legendre F, Ollitrault D, Hervieu M, Baugé C, Maneix L, Goux D, Chajra H, Mallein-Gerin F, Boumediene K, Galera P, Demoor M. Enhanced hyaline cartilage matrix synthesis in collagen sponge scaffolds by using siRNA to stabilize chondrocytes phenotype cultured with bone morphogenetic protein-2 under hypoxia.. Tissue Eng Part C Methods 2013 Jul;19(7):550-67.
    pubmed: 23270543doi: 10.1089/ten.TEC.2012.0508google scholar: lookup
  38. Kafienah W, Mistry S, Dickinson SC, Sims TJ, Learmonth I, Hollander AP. Three-dimensional cartilage tissue engineering using adult stem cells from osteoarthritis patients.. Arthritis Rheum 2007 Jan;56(1):177-87.
    pubmed: 17195220doi: 10.1002/art.22285google scholar: lookup
  39. Marlovits S, Aldrian S, Tichy B, Albrecht C, Nürnberger S. [Biomaterial for autologous chondrocyte transplantation].. Orthopade 2009 Nov;38(11):1045-52.
    pubmed: 19789853doi: 10.1007/s00132-009-1494-7google scholar: lookup
  40. Murphy MK, Huey DJ, Hu JC, Athanasiou KA. TGF-β1, GDF-5, and BMP-2 stimulation induces chondrogenesis in expanded human articular chondrocytes and marrow-derived stromal cells.. Stem Cells 2015 Mar;33(3):762-73.
    pubmed: 25377511doi: 10.1002/stem.1890google scholar: lookup
  41. Galéra P, Rédini F, Vivien D, Bonaventure J, Penfornis H, Loyau G, Pujol JP. Effect of transforming growth factor-beta 1 (TGF-beta 1) on matrix synthesis by monolayer cultures of rabbit articular chondrocytes during the dedifferentiation process.. Exp Cell Res 1992 Jun;200(2):379-92.
    pubmed: 1572404doi: 10.1016/0014-4827(92)90186-cgoogle scholar: lookup
  42. Ranera B, Lyahyai J, Romero A, Vázquez FJ, Remacha AR, Bernal ML, Zaragoza P, Rodellar C, Martín-Burriel I. Immunophenotype and gene expression profiles of cell surface markers of mesenchymal stem cells derived from equine bone marrow and adipose tissue.. Vet Immunol Immunopathol 2011 Nov 15;144(1-2):147-54.
    pubmed: 21782255doi: 10.1016/j.vetimm.2011.06.033google scholar: lookup
  43. Nishimura K, Solchaga LA, Caplan AI, Yoo JU, Goldberg VM, Johnstone B. Chondroprogenitor cells of synovial tissue.. Arthritis Rheum 1999 Dec;42(12):2631-7.
    pubmed: 10616011doi: 10.1002/1529-0131(199912)42:12<2631::AID-ANR18>3.0.CO;2-Hgoogle scholar: lookup
  44. Marinova-Mutafchieva L, Taylor P, Funa K, Maini RN, Zvaifler NJ. Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint.. Arthritis Rheum 2000 Sep;43(9):2046-55.
    pubmed: 11014356doi: 10.1002/1529-0131(200009)43:9<2046::AID-ANR16>3.0.CO;2-8google scholar: lookup
  45. Borchers K, Wolfinger U, Goltz M, Broll H, Ludwig H. Distribution and relevance of equine herpesvirus type 2 (EHV-2) infections.. Arch Virol 1997;142(5):917-28.
    pubmed: 9191857doi: 10.1007/s007050050128google scholar: lookup
  46. Bartlett DW, Davis ME. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.. Biotechnol Bioeng 2007 Jul 1;97(4):909-21.
    pubmed: 17154307doi: 10.1002/bit.21285google scholar: lookup
  47. Olive J, D'Anjou MA, Girard C, Laverty S, Theoret CL. Imaging and histological features of central subchondral osteophytes in racehorses with metacarpophalangeal joint osteoarthritis.. Equine Vet J 2009 Dec;41(9):859-64.
    pubmed: 20383982doi: 10.2746/042516409x448481google scholar: lookup
  48. Naito Y, Ui-Tei K. Designing functional siRNA with reduced off-target effects.. Methods Mol Biol 2013;942:57-68.
    pubmed: 23027045doi: 10.1007/978-1-62703-119-6_3google scholar: lookup
  49. Stewart AA, Byron CR, Pondenis H, Stewart MC. Effect of fibroblast growth factor-2 on equine mesenchymal stem cell monolayer expansion and chondrogenesis.. Am J Vet Res 2007 Sep;68(9):941-5.
    pubmed: 17764407doi: 10.2460/ajvr.68.9.941google scholar: lookup
  50. Doench JG, Petersen CP, Sharp PA. siRNAs can function as miRNAs.. Genes Dev 2003 Feb 15;17(4):438-42.
    pubmed: 12600936doi: 10.1101/gad.1064703google scholar: lookup
  51. Benya PD, Padilla SR, Nimni ME. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture.. Cell 1978 Dec;15(4):1313-21.
    pubmed: 729001doi: 10.1016/0092-8674(78)90056-9google scholar: lookup
  52. Filardo G, Kon E, Longo UG, Madry H, Marchettini P, Marmotti A, Van Assche D, Zanon G, Peretti GM. Non-surgical treatments for the management of early osteoarthritis.. Knee Surg Sports Traumatol Arthrosc 2016 Jun;24(6):1775-85.
    pubmed: 27043347doi: 10.1007/s00167-016-4089-ygoogle scholar: lookup
  53. Kim J, Kang JW, Park JH, Choi Y, Choi KS, Park KD, Baek DH, Seong SK, Min HK, Kim HS. Biological characterization of long-term cultured human mesenchymal stem cells.. Arch Pharm Res 2009 Jan;32(1):117-26.
    pubmed: 19183884doi: 10.1007/s12272-009-1125-1google scholar: lookup

Citations

This article has been cited 17 times.
  1. Jammes M, Contentin R, Cassé F, Galéra P. Equine osteoarthritis: Strategies to enhance mesenchymal stromal cell-based acellular therapies.. Front Vet Sci 2023;10:1115774.
    doi: 10.3389/fvets.2023.1115774pubmed: 36846261google scholar: lookup
  2. Shestovskaya MV, Bozhkova SA, Sopova JV, Khotin MG, Bozhokin MS. Methods of Modification of Mesenchymal Stem Cells and Conditions of Their Culturing for Hyaline Cartilage Tissue Engineering.. Biomedicines 2021 Nov 11;9(11).
    doi: 10.3390/biomedicines9111666pubmed: 34829895google scholar: lookup
  3. Nino-Fong R, Esparza Gonzalez BP, Rodriguez-Lecompte JC, Montelpare W, McD￮ L. Development of a biologically immortalized equine stem cell line.. Can J Vet Res 2021 Oct;85(4):293-301.
    pubmed: 34602734
  4. Bertoni L, Jacquet-Guibon S, Branly T, Desancé M, Legendre F, Melin M, Rivory P, Hartmann DJ, Schmutz A, Denoix JM, Demoor M, Audigié F, Galéra P. Evaluation of Allogeneic Bone-Marrow-Derived and Umbilical Cord Blood-Derived Mesenchymal Stem Cells to Prevent the Development of Osteoarthritis in An Equine Model.. Int J Mol Sci 2021 Mar 2;22(5).
    doi: 10.3390/ijms22052499pubmed: 33801461google scholar: lookup
  5. Bourdon B, Contentin R, Cassé F, Maspimby C, Oddoux S, Noël A, Legendre F, Gruchy N, Galéra P. Marine Collagen Hydrolysates Downregulate the Synthesis of Pro-Catabolic and Pro-Inflammatory Markers of Osteoarthritis and Favor Collagen Production and Metabolic Activity in Equine Articular Chondrocyte Organoids.. Int J Mol Sci 2021 Jan 8;22(2).
    doi: 10.3390/ijms22020580pubmed: 33430111google scholar: lookup
  6. Neybecker P, Henrionnet C, Pape E, Grossin L, Mainard D, Galois L, Loeuille D, Gillet P, Pinzano A. Respective stemness and chondrogenic potential of mesenchymal stem cells isolated from human bone marrow, synovial membrane, and synovial fluid.. Stem Cell Res Ther 2020 Jul 25;11(1):316.
    doi: 10.1186/s13287-020-01786-5pubmed: 32711576google scholar: lookup
  7. Al Naem M, Bourebaba L, Kucharczyk K, Röcken M, Marycz K. Therapeutic mesenchymal stromal stem cells: Isolation, characterization and role in equine regenerative medicine and metabolic disorders.. Stem Cell Rev Rep 2020 Apr;16(2):301-322.
    doi: 10.1007/s12015-019-09932-0pubmed: 31797146google scholar: lookup
  8. Contentin R, Demoor M, Concari M, Desancé M, Audigié F, Branly T, Galéra P. Comparison of the Chondrogenic Potential of Mesenchymal Stem Cells Derived from Bone Marrow and Umbilical Cord Blood Intended for Cartilage Tissue Engineering.. Stem Cell Rev Rep 2020 Feb;16(1):126-143.
    doi: 10.1007/s12015-019-09914-2pubmed: 31745710google scholar: lookup
  9. Zhang S, Hu P, Liu T, Li Z, Huang Y, Liao J, Hamid MR, Wen L, Wang T, Mo C, Alini M, Grad S, Wang T, Chen D, Zhou G. Kartogenin hydrolysis product 4-aminobiphenyl distributes to cartilage and mediates cartilage regeneration.. Theranostics 2019;9(24):7108-7121.
    doi: 10.7150/thno.38182pubmed: 31695756google scholar: lookup
  10. Gugjoo MB, Fazili MR, Gayas MA, Ahmad RA, Dhama K. Animal mesenchymal stem cell research in cartilage regenerative medicine - a review.. Vet Q 2019 Dec;39(1):95-120.
    doi: 10.1080/01652176.2019.1643051pubmed: 31291836google scholar: lookup
  11. Zhang X, Qi L, Chen Y, Xiong Z, Li J, Xu P, Pan Z, Zhang H, Chen Z, Xue K, Liu K. The in vivo chondrogenesis of cartilage stem/progenitor cells from auricular cartilage and the perichondrium.. Am J Transl Res 2019;11(5):2855-2865.
    pubmed: 31217859
  12. Bertoni L, Branly T, Jacquet S, Desancé M, Desquilbet L, Rivory P, Hartmann DJ, Denoix JM, Audigié F, Galéra P, Demoor M. Intra-Articular Injection of 2 Different Dosages of Autologous and Allogeneic Bone Marrow- and Umbilical Cord-Derived Mesenchymal Stem Cells Triggers a Variable Inflammatory Response of the Fetlock Joint on 12 Sound Experimental Horses.. Stem Cells Int 2019;2019:9431894.
    doi: 10.1155/2019/9431894pubmed: 31191689google scholar: lookup
  13. Bourebaba L, Röcken M, Marycz K. Osteochondritis dissecans (OCD) in Horses - Molecular Background of its Pathogenesis and Perspectives for Progenitor Stem Cell Therapy.. Stem Cell Rev Rep 2019 Jun;15(3):374-390.
    doi: 10.1007/s12015-019-09875-6pubmed: 30796679google scholar: lookup
  14. Viganò M, Tessaro I, Trovato L, Colombini A, Scala M, Magi A, Toto A, Peretti G, de Girolamo L. Rationale and pre-clinical evidences for the use of autologous cartilage micrografts in cartilage repair.. J Orthop Surg Res 2018 Nov 6;13(1):279.
    doi: 10.1186/s13018-018-0983-ypubmed: 30400946google scholar: lookup
  15. Rakic R, Bourdon B, Demoor M, Maddens S, Saulnier N, Galéra P. Differences in the intrinsic chondrogenic potential of equine umbilical cord matrix and cord blood mesenchymal stromal/stem cells for cartilage regeneration.. Sci Rep 2018 Sep 14;8(1):13799.
    doi: 10.1038/s41598-018-28164-9pubmed: 30217993google scholar: lookup
  16. Branly T, Contentin R, Desancé M, Jacquel T, Bertoni L, Jacquet S, Mallein-Gerin F, Denoix JM, Audigié F, Demoor M, Galéra P. Improvement of the Chondrocyte-Specific Phenotype upon Equine Bone Marrow Mesenchymal Stem Cell Differentiation: Influence of Culture Time, Transforming Growth Factors and Type I Collagen siRNAs on the Differentiation Index.. Int J Mol Sci 2018 Feb 1;19(2).
    doi: 10.3390/ijms19020435pubmed: 29389887google scholar: lookup
  17. Rakic R, Bourdon B, Hervieu M, Branly T, Legendre F, Saulnier N, Audigié F, Maddens S, Demoor M, Galera P. RNA Interference and BMP-2 Stimulation Allows Equine Chondrocytes Redifferentiation in 3D-Hypoxia Cell Culture Model: Application for Matrix-Induced Autologous Chondrocyte Implantation.. Int J Mol Sci 2017 Aug 24;18(9).
    doi: 10.3390/ijms18091842pubmed: 28837082google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.